Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling

BACKGROUND: Fuzi-Lizhong decoction (FLD) derives from the ancient Chinese Pharmacopoeia and has been clinically used for years. The present study aimed to investigate the activities and underlying mechanisms of FLD against nonalcoholic fatty liver disease (NAFLD). METHODS: In vivo studies were condu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiayao, Zhang, Ying, Yi, Hongfeng, Liao, Yan, Shu, Lei, Zhang, Shu, Li, Chenyu, An, Liu, Du, Nianlong, Shi, Zhaohong, Ma, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440633/
https://www.ncbi.nlm.nih.gov/pubmed/36065267
http://dx.doi.org/10.1155/2022/1637701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440633/
https://www.ncbi.nlm.nih.gov/pubmed/36065267
http://dx.doi.org/10.1155/2022/1637701

Ejemplares similares